CRESTA, FEDERICO
 Distribuzione geografica
Continente #
EU - Europa 1.865
AS - Asia 264
NA - Nord America 154
SA - Sud America 20
OC - Oceania 14
AF - Africa 4
Totale 2.321
Nazione #
IT - Italia 1.818
US - Stati Uniti d'America 146
SG - Singapore 117
CN - Cina 69
VN - Vietnam 49
AU - Australia 14
BR - Brasile 13
DE - Germania 11
HK - Hong Kong 11
FR - Francia 10
CA - Canada 6
AR - Argentina 4
FI - Finlandia 4
ID - Indonesia 4
IQ - Iraq 4
NL - Olanda 4
GB - Regno Unito 3
IE - Irlanda 3
JP - Giappone 3
BD - Bangladesh 2
CL - Cile 2
IN - India 2
LT - Lituania 2
MA - Marocco 2
MX - Messico 2
PL - Polonia 2
UA - Ucraina 2
EE - Estonia 1
ES - Italia 1
IL - Israele 1
KZ - Kazakistan 1
MU - Mauritius 1
NG - Nigeria 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SE - Svezia 1
Totale 2.321
Città #
Genoa 769
Genova 704
Rapallo 167
Vado Ligure 161
San Jose 58
Singapore 57
Council Bluffs 22
Ho Chi Minh City 18
Beijing 13
Hong Kong 11
Lauterbourg 9
Frankfurt am Main 8
Santa Clara 8
Ashburn 7
Hanoi 7
Haiphong 6
New York 5
Helsinki 4
Milan 4
Amsterdam 3
Ninh Bình 3
Tokyo 3
Bordighera 2
Dublin 2
Macapá 2
Melbourne 2
Potenza 2
Rome 2
Sinnai 2
Vĩnh Tường 2
Warsaw 2
Agadir 1
Almaty 1
Arlington 1
Atlanta 1
Bandung 1
Banyuwangi 1
Baqubah 1
Basingstoke 1
Belgrade 1
Betim 1
Biên Hòa 1
Brandon 1
Brooklyn 1
Bắc Giang 1
Bắc Ninh 1
Calgary 1
Can Tho 1
Capim Branco 1
Chehalis 1
Chicago 1
Concepción 1
Da Nang 1
Dammam 1
Denver 1
Edison 1
Elizabeth 1
Fes 1
Fortaleza 1
Francisco Beltrão 1
Garibaldi 1
Gobernador Virasoro 1
Gravataí 1
Hải Dương 1
Itabuna 1
Leipzig 1
London 1
Los Angeles 1
Lévis 1
Madrid 1
Marseille 1
Mexico City 1
Mineiros 1
Monte Grande 1
Montreal 1
Morelia 1
Mosul 1
Newark 1
Nha Trang 1
North Bergen 1
Nuremberg 1
Orem 1
Phúc Yên 1
Ploieşti 1
Port Louis 1
Putian 1
Ribeirão Preto 1
Rio de Janeiro 1
Roccalumera 1
Saint Joseph 1
San Vicente 1
Santa Rita 1
Santiago 1
Shanghai 1
Slough 1
Stockholm 1
Sulaymaniyah 1
Sydney 1
Tallinn 1
Tel Aviv 1
Totale 2.134
Nome #
Abnormal activation of calpain and protein kinase Cα promotes a constitutive release of matrix metalloproteinase 9 in peripheral blood mononuclear cells from cystic fibrosis patients 241
Evidence for alteration of calpain/calpastatin system in PBMC of cystic fibrosis patients 220
Calpain inhibition promotes the rescue of F(508)del-CFTR in PBMC from cystic fibrosis patients. 195
Pathological role of the calpain/calpastatin system in cystic fibrosis 176
Verso un approccio personalizzato per il trattamento del difetto di base in Fibrosi Cistica 170
The calpain-calpastatin system in cystic fibrosis: physiopathological implications 158
The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin 153
A case of interference in testosterone, DHEA-S and progesterone measurements by second generation immunoassays 142
The L467F-F508del Complex Allele Hampers Pharmacological Rescue of Mutant CFTR by Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients: The Value of the Ex Vivo Nasal Epithelial Model to Address Non-Responders to CFTR-Modulating Drugs 134
Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells 123
Rescue by elexacaftor-tezacaftor-ivacaftor of the G1244E cystic fibrosis mutation's stability and gating defects are dependent on cell background 95
Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method 86
Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study 70
Therapeutic monitoring of Ivacaftor, Tezacaftor and Elexacaftor in patients with cystic fibrosis|Monitoraggio terapeutico di Ivacaftor, Tezacaftor e Elexacaftor in pazienti con fibrosi cistica 70
QUANTIFICATION OF IVACAFTOR, TEZACAFTOR, AND ELEXACAFTOR IN PLASMA OF CYSTIC FIBROSIS PATIENTS BY AN HPLC–MS/MS METHOD 68
Quantification of Ivacaftor, Tezacaftor and Elexacaftor in plasma of cystic fibrosis patients treated with Kaftrio by a validated liquid chromatography-tandem mass spectrometric (LC-MS/MS) method” 63
Pharmacological rescue of the G85E CFTR variant by preclinical and approved modulators 61
One-Year Effect of Elexacaftor/Tezacaftor/Ivacaftor Therapy on HbA1c Levels and Insulin Requirement in Patients with Insulin-Dependent Cystic Fibrosis-Related Diabetes: A Retrospective Observational Study 56
A Novel LC-MS/MS Method for the Measurement of Elexacaftor, Tezacaftor and Ivacaftor in Plasma, Dried Plasma Spot (DPS) and Whole Blood in Volumetric Absorptive Microsampling (VAMS) Devices 53
In silico, in vitro and ex vivo characterization of cystic fibrosis transmembrane conductance regulator pathogenic variants localized in the fourth intracellular loop and their rescue by modulators 27
Totale 2.361
Categoria #
all - tutte 7.259
article - articoli 5.378
book - libri 0
conference - conferenze 1.370
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.007


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 0 0 7 9 9
2021/2022143 2 3 16 8 4 8 8 30 4 15 25 20
2022/2023207 13 22 0 29 18 31 4 16 37 3 33 1
2023/2024129 5 10 3 18 15 26 5 8 2 4 12 21
2024/2025546 14 27 21 30 33 59 31 119 46 45 55 66
2025/2026751 127 24 49 64 116 48 124 40 87 72 0 0
Totale 2.361